Parallax Volatility Advisers’s Accelerate Diagnostics AXDX Stock Holding History

Parallax Volatility Advisers’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-30	Closed	-$3K	–	2760
2018 Q4	$3K	Buy	+30	New	+$4.45K	﹤0.01%	2618
2018 Q1	–	Sell	-700	Closed	-$183K	–	2268
2017 Q4	$183K	Sell	700 -4,750	-87%	-$1.11M	﹤0.01%	2353
2017 Q3	$1.22M	Buy	+5,450	New	+$1.34M	﹤0.01%	1003
2017 Q1	–	Sell	-3,000	Closed	-$623K	–	3534
2016 Q4	$623K	Buy	+3,000	New	+$712K	﹤0.01%	1421

Other funds holding AXDX

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Parallax Volatility Advisers's AXDX Position: Q4 2018 in Review

Parallax Volatility Advisers sold out of Accelerate Diagnostics (AXDX) in Q4 2018, closing a stake of 1,084 shares — an estimated $161K sold.

Parallax Volatility Advisers first reported a position in AXDX in Q2 2017 and held it in 5 quarters. The position peaked at $710K in Q2 2017. 107 funds tracked by Wall St. Rank hold AXDX as of Q4 2018.

Parallax Volatility Advisers reported no remaining Accelerate Diagnostics position as of Q4 2018 after selling out during the quarter.
Parallax Volatility Advisers sold 1,084 Accelerate Diagnostics shares in Q4 2018, an estimated $161K.
Parallax Volatility Advisers first reported a position in Accelerate Diagnostics in Q2 2017 and held it in 5 quarters.
Parallax Volatility Advisers's Accelerate Diagnostics position peaked at $710K in Q2 2017.
107 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2018.

Based on Parallax Volatility Advisers's 13F filing for Q4 2018, filed 14 Feb 2019.